40 years after the registration of acyclovir: do we need new anti-herpetic drugs?

A Majewska, B Mlynarczyk-Bonikowska - International journal of …, 2022 - mdpi.com
Herpes simplex virus types 1 and 2 HSV1 and 2, namely varicella-zoster VZV and
cytomegalovirus CMV, are among the most common pathogens worldwide. They remain in …

Database on natural polymorphisms and resistance-related non-synonymous mutations in thymidine kinase and DNA polymerase genes of herpes simplex virus types …

A Sauerbrei, K Bohn-Wippert, M Kaspar… - Journal of …, 2016 - academic.oup.com
The use of genotypic resistance testing of herpes simplex virus types 1 and 2 (HSV-1 and
HSV-2) is increasing because the rapid availability of results significantly improves the …

Acyclovir-resistant herpes simplex virus 1 keratitis: a concerning and emerging clinical challenge

A Rousseau, SB Pharm, J Gueudry, C Deback… - American journal of …, 2022 - Elsevier
Purpose To describe the clinical and virological profiles of patients with herpes simplex
keratitis (HSK) caused by acyclovir-resistant (ACV R) strains of herpes simplex virus 1 (HSV …

[HTML][HTML] Nonthermal dielectric barrier discharge (DBD) plasma suppresses herpes simplex virus type 1 (HSV-1) replication in corneal epithelium

O Alekseev, K Donovan, V Limonnik… - … vision science & …, 2014 - iovs.arvojournals.org
Purpose:: Herpes keratitis (HK) is the leading cause of cornea-derived and infection-
associated blindness in the developed world. Despite the availability of effective antivirals …

Sequence analysis of herpes simplex virus 1 thymidine kinase and DNA polymerase genes from over 300 clinical isolates from 1973 to 2014 finds novel mutations …

S Schmidt, K Bohn-Wippert… - Antimicrobial Agents …, 2015 - Am Soc Microbiol
ABSTRACT A total of 302 clinical herpes simplex virus 1 (HSV-1) strains, collected over 4
decades from 1973 to 2014, were characterized retrospectively for drug resistance. All HSV …

Acyclovir‐resistant HSV‐1 isolates among immunocompromised patients in southern Taiwan: Low prevalence and novel mutations

JY Kuo, CS Yeh, SM Wang, SH Chen… - Journal of Medical …, 2023 - Wiley Online Library
Herpes simplex virus type 1 (HSV‐1) can establish latency in humans and easily relapse in
immunocompromised patients, with significant mortality. Treatment with acyclovir (ACV) can …

Comparison of three cell-based drug screening platforms for HSV-1 infection

L D'Aiuto, K Williamson, P Dimitrion, J McNulty… - Antiviral research, 2017 - Elsevier
Acyclovir (ACV) and its derivatives have been highly effective for treating recurrent, lytic
infections with Herpes Simplex Virus, type 1 (HSV-1), but searches for additional antiviral …

[PDF][PDF] Neurotoxic side effects of acyclovir: two case reports

Z Paluch, M Trojánek, Z Velíšková, J Mlíchová… - Neuroendocrinol Lett, 2021 - nel.edu
Acyclovir is an antiviral drug frequently used in clinical practice. It is indicated for the
treatment of infections caused by herpes simplex virus and varicella zoster virus. The drug …

Inhibition of ataxia telangiectasia mutated (ATM) kinase suppresses herpes simplex virus type 1 (HSV-1) keratitis

O Alekseev, K Donovan… - … ophthalmology & visual …, 2014 - iovs.arvojournals.org
Purpose.: Herpes keratitis (HK) remains the leading cause of cornea-derived blindness in
the developed world, despite the availability of effective antiviral drugs. Treatment toxicity …

Recombinant herpes simplex virus type 1 strains with targeted mutations relevant for aciclovir susceptibility

AK Brunnemann, K Liermann, S Deinhardt-Emmer… - Scientific reports, 2016 - nature.com
Here, we describe a novel reliable method to assess the significance of individual mutations
within the thymidine kinase (TK) gene of herpes simplex virus type 1 (HSV-1) to nucleoside …